Literature DB >> 18390029

Cholestasis secondary to panhypopituitarism in an infant.

Daniel DeSalvo1, John F Pohl, Don P Wilson, William Bryant, David Easley, John Greene, Jose Santiago.   

Abstract

Cholestasis occurring in infancy should be evaluated completely to exclude hepatic as well as endocrine or metabolic causes. A rapid diagnosis should be made to ensure that hepatic and neurologic complications are prevented. We describe a rare case of infant cholestasis due to panhypopituitarism resulting in hypoglycemia and liver biopsy findings consistent with bile duct paucity. Existing bile ducts were noted to be small, and electron microscopy demonstrated diminutive and atrophied biliary cells with a diminished bile duct lumen size. Hypoglycemia and cholestasis resolved with treatment of the underlying panhypopituitarism. Panhypopituitarism should be considered in any infant who presents with cholestasis, hypoglycemia, and other manifestations of pituitary malfunction. Growth hormone deficiency may affect bile duct formation as demonstrated in this patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390029     DOI: 10.1016/s0027-9684(15)31249-9

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  4 in total

1.  Cholestasis caused by panhypopituitarism and acquired cytomegalovirus infection in a 2-month-old male infant: A case report.

Authors:  U Chan; Wai-Tao Chan; Wei-Hsin Ting; Che-Sheng Ho; Hsi-Che Liu; Hung-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

2.  Isolated cortisol deficiency: a rare cause of neonatal cholestasis.

Authors:  Abdulrahman Al-Hussaini; Awatif Almutairi; Alaaddin Mursi; Mohammed Alghofely; Ali Asery
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

3.  Cholestasis Reveals Severe Cortisol Deficiency in Neonatal Pituitary Stalk Interruption Syndrome.

Authors:  Francois-Xavier Mauvais; Emmanuel Gonzales; Anne Davit-Spraul; Emmanuel Jacquemin; Raja Brauner
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 4.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.